Corrigendum to “The use of the biosimilar drug can lead to large health care savings that can be reinvested for continued innovation: Analysis of consumption of an Italian health care company” J. Cancer Policy. 40 (2024) 100473
-
Published:2024-09
Issue:
Volume:41
Page:100480
-
ISSN:2213-5383
-
Container-title:Journal of Cancer Policy
-
language:en
-
Short-container-title:Journal of Cancer Policy
Author:
Ferrara FrancescoORCID,
Capuozzo MaurizioORCID,
Langella Roberto,
Trama Ugo,
Nava Eduardo,
Zovi AndreaORCID